DC Circ. Has Doubts About Narcolepsy Drug Appeal
By Nadia Dreid · May 5, 2025, 11:02 PM EDT
The D.C. Circuit is now set to decide whether the U.S. Food and Drug Administration was wrong to declare a rival narcolepsy treatment not the "same drug" as another produced by...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login